SHANGHAI KINETIC MEDICAL CO., LTD Shanghai Kinetic Medical Co., Ltd Stock
Equities
300326
CNE100001FG9
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.66 CNY | -0.43% |
|
+7.62% | -26.38% |
| Sales 2024 * | 1.13B 156M | Sales 2025 * | 1.36B 188M | Capitalization | 3.34B 461M |
|---|---|---|---|---|---|
| Net income 2024 * | 122M 16.84M | Net income 2025 * | 147M 20.29M | EV / Sales 2024 * | 2.95 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.46 x |
| P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
23.3
x | Employees | 1,045 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.97% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.43% | ||
| 1 week | +7.62% | ||
| Current month | -7.17% | ||
| 1 month | -10.56% | ||
| 3 months | -13.86% | ||
| 6 months | -25.80% | ||
| Current year | -26.38% |
1 week
4.48
4.72
1 month
4.315.23
Current year
4.066.44
1 year
4.067.18
3 years
4.0614.51
5 years
4.0631.38
10 years
4.0631.38
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Min Wang
CEO | Chief Executive Officer | 56 | 07-01-31 |
Yuan Ping Li
DFI | Director of Finance/CFO | 45 | 17-01-31 |
Zheng Yuan
CHM | Chairman | 61 | 04-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zheng Yuan
CHM | Chairman | 61 | 04-12-31 |
Zhi Qiang Zhou
CHM | Chairman | 70 | 09-12-31 |
Ye Zhou
BRD | Director/Board Member | 40 | 07-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 4.66 | -0.43% | 5,821,200 |
| 24-04-23 | 4.68 | +1.30% | 7,221,171 |
| 24-04-22 | 4.62 | +2.44% | 8,963,782 |
| 24-04-19 | 4.51 | -1.10% | 4,415,660 |
| 24-04-18 | 4.56 | -1.08% | 5,691,634 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotes
Shanghai Kinetic Medical Co., Ltd is a China-based company principally engaged in the research, development, manufacture and sale of minimally invasive surgical systems. The Company is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The Company operates its business in domestic market.
Calendar
2024-05-22
- Annual General Meeting
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.66
CNY
Average target price
4.76
CNY
Spread / Average Target
+2.15%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.38% | 463M | |
| -2.89% | 187B | |
| -2.43% | 108B | |
| -4.10% | 67.71B | |
| +11.10% | 53.07B | |
| +15.86% | 47.36B | |
| +6.01% | 39.73B | |
| +9.55% | 28.56B | |
| +1.85% | 26.55B | |
| +15.97% | 25.13B |
- Stock Market
- Equities
- 300326 Stock
